Xanthoangelol, a major chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma and leukemia cells

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 8, 2005, Pages 1404-1407

  Tabata, Keiichi ^a   Motani, Kou ^a   Takayanagi, Noriya ^a   Nishimura, Reiko ^a   Asami, Satoru ^a   Kimura, Yumiko ^a   Ukiya, Motohiko ^a   Hasegawa, Daisuke ^a   Akihisa, Toshihiro ^a   Suzuki, Takashi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Apoptosis; Leukemia; Neuroblastoma; Xanthoangelol

Indexed keywords

3' C GERANYL 2',4,4' TRIHYDROXYCHALCONE; ANGELICA EXTRACT; ANTINEOPLASTIC AGENT; CASPASE 3; CHALCONE; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BCL 2; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANGELICA; ANGELICA KEISKEI; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL SURVIVAL; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG SCREENING; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKEMIA CELL; LEUKEMIA CELL LINE; MEDICINAL PLANT; MOLECULAR MECHANICS; NEUROBLASTOMA CELL; PLANT STEM; PROTEIN DEGRADATION; ROOT EXUDATE; SIGNAL TRANSDUCTION; STAINING; SURVIVAL RATE; WESTERN BLOTTING;

ANGELICA; APOPTOSIS; CASPASE 3; CASPASES; CHALCONE; ENZYME ACTIVATION; HUMANS; LEUKEMIA; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 25644435490     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1404     Document Type: Article

References (22)

1. Maris J. M., Matthay K. K., J. Clin. Oncol., 17, 2264-2279 (1999).
2. Poulaki V., Mitsiades N., Romero M. E., Tsokos M., Cancer Res., 61, 4864-4872 (2001).
3. Ogawa H., Nakashima S., Baba K., Clin. Exp. Pharmacol. Physiol., 30, 284-288 (2003).
4. Park J. C., Park J. G., Kim H. J., Hur J. M., Lee J. H., Sung N. J., Chung S. K., Choi J. W., Phytother. Res., 16, S24-S27 (2002).
5. Matsuura M., Kimura Y., Nakata K., Baba K., Okuda H., Planta Med., 67, 230-235 (2001).
6. Akihisa T., Tokuda H., Ukiya M., Iizuka M., Schneider S., Ogasawara K., Mukainaka T., Iwatsuki K., Suzuki T., Nishino H., Cancer Lett., 201, 133-137 (2003).
7. Okuyama T., Takata M., Takayasu J., Hasegawa T., Tokuda H., Nishino A., Nishino H., Iwashima A., Planta Med., 57, 242-246 (1991).
8. Kimura Y., Baba K., Int. J. Cancer, 106, 429-437 (2003).
9. Hayashi A., Gillen A. C., Lott J. R., Altern. Med. Rev., 5, 546-552 (2000).
10. Bradford M. M., Anal. Biochem., 72, 248-54 (1976).
11. Okuyama T., Takata M., Nishino H., Nishino A., Takayasu J., Iwashima A., Chem. Pharm. Bull., 38, 1084-1086 (1990).
12. Oue T., Fukuzawa M., Kusafuka T., Kohmoto Y., Imura K., Nagahara S., Okada A., J. Pediatr. Surg., 31, 251-257 (1996).
13. Park S. A., Park H. J., Lee B. I., Ahn Y. H., Kim S. U., Choi K. S., Mol. Brain Res., 93, 18-26 (2001).
14. Kim Y. S., Jin S. H., Arch. Pharm. Res., 27, 834-839 (2004).
15. Yakovlev A. G., Di Giovanni S., Wang G., Liu W., Stoica B., Faden A. I., J. Biol. Chem., 279, 28367-28374 (2004).
16. Hopkins-Donaldson S., Yan P., Bourloud K. B., Muhlethaler A., Bodmer J. L., Gross N., Oncogene 21, 6132-6137 (2002).
17. Kisenge R. R., Toyoda H., Kang J., Tanaka S., Yamamoto H., Azuma E., Komada Y., Cancer Sci., 94, 598-605 (2003).
18. van Noesel M. M., Versteeg R., Gene, 325, 1-15 (2004).
19. Iwafuchi M., Utsumi J., Tsuchida Y., Kaneko M., Matsuyama S., Ohnuma N., Taguchi N., Mugishima H., Yokoyama J., Sasaki S., Yoshioka A., Nagahara N., Fukuzawa M., Suita S., Med. Pediatr. Oncol., 27, 515-520 (1996).
20. Lee J. H., Park J. H., Yang M. H., J. Kor. Med. Sci., 12, 185-189 (1997).
21. Dole M. G., Jasty R., Cooper M. J., Thompson C. B., Nunez G., Castle V. P., Cancer Res., 55, 2576-2582 (1995).
22. Bian X., Giordano T. D., Lin H. J., Solomon G., Castle V. P., Opipari A. W., Jr., J. Biol. Chem., 279, 4663-4669 (2004).